Monica Veldman

Company: Alliance for Regenerative Medicine

Job title: Director, Global Regulatory Policy

Seminars:

Panel Discussion: Exploring Recent Guidance on Platform Technologies to Clarify Frameworks for Approaches Used Across the Cell & Gene Field 2:00 pm

Considering what should be included on a platform basis or potentially excluded from a CMC, non-clinical, or procedural basis Enhancing the developmental process and efficiency by understanding the versatility of platform technologies and clarifying guidance on approaches Leveraging standardized systems to expedite the production of several cell and gene therapy productsRead more

day: Conference Day Two